Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,074,588
  • Shares Outstanding, K 44,356
  • Annual Sales, $ 2,328 M
  • Annual Income, $ 984,800 K
  • 60-Month Beta 0.54
  • Price/Sales 5.20
  • Price/Cash Flow 12.21
  • Price/Book 2.24
Trade UTHR with:

Options Overview Details

View History
  • Implied Volatility 22.20% ( -0.01%)
  • Historical Volatility 30.32%
  • IV Percentile 3%
  • IV Rank 13.13%
  • IV High 34.81% on 02/14/24
  • IV Low 20.29% on 09/15/23
  • Put/Call Vol Ratio 1.74
  • Today's Volume 1,309
  • Volume Avg (30-Day) 764
  • Put/Call OI Ratio 1.53
  • Today's Open Interest 26,118
  • Open Int (30-Day) 22,876

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 6.13
  • Number of Estimates 9
  • High Estimate 6.50
  • Low Estimate 5.55
  • Prior Year 5.24
  • Growth Rate Est. (year over year) +16.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
233.27 +17.57%
on 04/24/24
275.00 -0.27%
on 05/15/24
+38.95 (+16.55%)
since 04/17/24
3-Month
213.75 +28.31%
on 02/20/24
275.00 -0.27%
on 05/15/24
+59.53 (+27.72%)
since 02/16/24
52-Week
204.44 +34.15%
on 05/30/23
275.00 -0.27%
on 05/15/24
+58.07 (+26.86%)
since 05/17/23

Most Recent Stories

More News
United Therapeutics: Q1 Earnings Snapshot

United Therapeutics: Q1 Earnings Snapshot

UTHR : 274.26 (+0.75%)
United Airlines, Dyne Therapeutics fall; Lucid Group, Century Aluminum rise, Monday, 3/25/2024

Stocks that traded heavily or had substantial price changes on Monday: United Airlines, Dyne Therapeutics fall; Lucid Group, Century Aluminum rise

CLV : 1.43 (-0.69%)
CLF : 17.51 (-0.91%)
UTHR : 274.26 (+0.75%)
CENX : 17.85 (+3.66%)
INTC : 31.83 (-0.62%)
BA : 184.95 (+1.09%)
UAL : 54.97 (+0.35%)
United Therapeutics: Q4 Earnings Snapshot

United Therapeutics: Q4 Earnings Snapshot

UTHR : 274.26 (+0.75%)
United Therapeutics: Q3 Earnings Snapshot

United Therapeutics: Q3 Earnings Snapshot

UTHR : 274.26 (+0.75%)
Markets Today: Stocks Fall as Fitch Cuts its U.S. Debt Rating

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.61%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.88%. Stock indexes this morning are lower after Fitch Ratings’...

ESM24 : 5,327.25s (+0.13%)
NQM24 : 18,635.25s (-0.08%)
GNRC : 144.77 (+1.24%)
PINS : 42.78 (+0.02%)
SBUX : 77.85 (+3.41%)
CCL : 15.00 (+0.67%)
EA : 127.75 (-1.09%)
CWH : 20.52 (-2.01%)
NCLH : 15.75 (-0.88%)
VFC : 12.76 (-2.15%)
CVS : 57.68 (+0.28%)
ELF : 158.45 (-2.35%)
United Therapeutics: Q2 Earnings Snapshot

United Therapeutics: Q2 Earnings Snapshot

UTHR : 274.26 (+0.75%)
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.

DNLI : 20.51 (+1.33%)
RARE : 41.87 (-1.74%)
SRPT : 131.38 (-1.02%)
PFE : 28.64 (-0.97%)
EXEL : 20.91 (-1.51%)
MRNA : 132.90 (+0.17%)
UTHR : 274.26 (+0.75%)
BIIB : 230.57 (+0.23%)
SNY : 48.67 (-0.31%)
LLY : 770.00 (-0.15%)
Here's What Key Metrics Tell Us About United Therapeutics (UTHR) Q1 Earnings

The headline numbers for United Therapeutics (UTHR) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street...

UTHR : 274.26 (+0.75%)
United Therapeutics (UTHR) Q1 Earnings Beat Estimates

United Therapeutics (UTHR) delivered earnings and revenue surprises of 11.72% and 1.46%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

UTHR : 274.26 (+0.75%)
ONCT : 8.66 (-1.87%)
United Therapeutics: Q1 Earnings Snapshot

United Therapeutics: Q1 Earnings Snapshot

UTHR : 274.26 (+0.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 279.97
2nd Resistance Point 277.23
1st Resistance Point 275.74
Last Price 274.26
1st Support Level 271.52
2nd Support Level 268.78
3rd Support Level 267.29

See More

52-Week High 275.00
Last Price 274.26
Fibonacci 61.8% 248.05
Fibonacci 50% 239.72
Fibonacci 38.2% 231.39
52-Week Low 204.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar